New international research finds that people living with multiple sclerosis (MS) prioritise slowing disease progression when considering treatment choices. People with MS want therapies that reduce the number of relapses they experience and to achieve better control of symptoms like fatigue and pain... Read more - http://www.ms-uk.org/more-effective-mul ... disability
